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INTRODUCTION
Paraquat (1,1′ -dimethyl-4, 4′ -bipyridium dichloride, PQ)
is one of the most widely used herbicides in the world. In
humans, intentional or accidental ingestion of PQ is frequent-
ly fatal, resulting from significant lung injury (1). Over the
past 30 yr, several methods for modifying the toxicity of PQ
have been investigated including prevention of absorption
from the gastrointestinal tract (2, 3), removal from the blood-
stream (4, 5), prevention of accumulation in the lungs (6, 7),
scavenging oxygen free radicals (8, 9), and prevention of lung
fibrosis (10, 11). Unfortunately, most of these methods have
not been effective; and the clinical outcome is determined
by the degree of exposure to PQ. PQ mainly accumulates in
the lung where it is retained even when the blood levels start
to decrease. Subsequent redox cycling and the generation of
reactive oxygen species (ROS) trigger the lung injury (12, 13).
This is the reason why intentional or accidental PQ ingestion
frequently causes death by respiratory failure (12).
There are many methods available for evaluation of the
severity of lung injury in acute PQ intoxication, such as arte-
rial blood gas analysis (aBGA), high-resolution computed
tomography (HRCT) of the lung (14). Also there are some
markers for alveolar destruction in acute PQ intoxication,
such as ethane in exhaled breath (15), and plasma surfactant
levels (16). 
We previously reported that HRCT of the lung obtained
7 days after PQ ingestion was the best way to evaluate the
fully developed acute PQ lung injury (14). The initial pathol-
ogy of the lung is alveolitis, which develops into ground glass
opacities (GGOs) in HRCT. The mortality rate is strongly
associated with the plasma PQ levels as well as the amount
of PQ ingested (17-19). 
Considering the significant association of the PQ level with
clinical outcome and the fact that respiratory failure is the
main cause of death, the extent of the lung injury might be
related to the plasma PQ levels. Nevertheless, the correlation
of the extent of the lung injury with plasma PQ levels and
clinical outcome is unknown. To determine the association
of the development of GGOs with plasma PQ levels and clini-
cal outcome, we analyzed the results of lung HRCT scans
obtained in patients with acute PQ intoxication and attempt-
ed to determine the factors that distinguished the survivors
from those that did not survive. 
MATERIALS AND METHODS
This study was approved by ethics committee of Soonchun-
hyang University Cheonan Hospital and received a written
consent from the patients and/or their family. From January
to November 2007, 250 patients (143 males and 107 females)
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The Area of Ground Glass Opacities of the Lungs as a Predictive
Factor in Acute Paraquat Intoxication 
Even though plasma paraquat (PQ) levels have known to be an informative predic-
tor, many patients succumb at low PQ levels in acute PQ intoxication. This study
was designed to see whether the high resolution computerized tomography (HRCT)
of the lungs would be a predictive measure in acute PQ intoxication. HRCT of the
lungs was obtained from 119 patients with acute PQ intoxication on 7 days after PQ
ingestion. The areas with ground glass opacities (GGOs) were evaluated at five levels
with the area measurement tool of the picture archiving and communication systems.
Among 119 patients, 102 survived and 17 died. The plasma PQ levels were signif-
icantly higher in the non-survivors than in the survivors (2.6±4.0 μ g/mL vs. 0.2±0.4
μ g/mL, P=0.02). The area with GGOs was 2.0±6.4% in the survivors and 73.0±
29.9% in the non-survivors (P<0.001). No patients survived when the area with GGOs
was more than 40% but all of the patients survived when the area affected by GGOs
was less than 20%. In conclusion, the area of GGOs is a useful predictor of survival
in acute PQ intoxication, especially in patients with low plasma PQ levels.
Key Words : Paraquat; Lung; High Resolution Computerized Tomography; Predictive Measure; Ground Glass
Opacities
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with acute PQ intoxication were admitted to the Institute of
Pesticide Poisoning (IPP), Soonchunhyang University Cheo-
nan Hospital. Standardized medical emergency procedures
were conducted, which were summarized Table 1. Of 250
patients 119 (68 males and 51 females) were enrolled in this
study. The inclusion criteria were patients who swallowed
PQ and had acute PQ intoxication confirmed at the IPP with
the dithionite urine test and/or plasma PQ levels. All of the
enrolled patients had HRCT, 7 days after the PQ ingestion.
The patients that died prior to 7 days were excluded from the
study. HRCT was not done in 131 patients who were dead
or hopelessly discharged within 7 days after PQ ingestion.
As we described in a previous report (20), the survivor was
defined as the patient who remained alive longer than 4 weeks
after discharge.
The mean age of the subjects was 43.3±12.2 yr. The in-
gestion amount (mean; 25.0±23.9 mL of 23% PQ; in Korea,
most PQ products are a 23.0% solution) was determined by
the reported mouthfuls ingested (one mouthful; 20 mL). The
plasma PQ level of the subjects in the emergency room was
0.57±1.72 μ g/mL retrospectively. 
The time interval between PQ ingestion and arrival to the
IPP was 21.2±30.3 hr.
Measurement of GGOs area on HRCT (Fig. 1)
All HRCT scans were obtained 7 days after PQ poisoning
using an eight-detector (LightSpeed Ultra, GE Healthcare)
or 64-detector (LightSpeed VCT, GE Healthcare, U.S.A.) row
scanners. The scanning parameters were 120 kVp, 200 or 300
mA, beam width 10 or 20 mm, and a pitch of 1.675 or 1.375.
The 1.25 mm thin-section computed tomography (CT) scans
with 5 mm intervals were acquired using retrospective recon-
struction of raw data with a lung algorithm. HRCT images
were available at a picture archiving and communication sys-
tems (PACS) with appropriate lung (window width, 1500,
window level, -650) window settings on the monitors (four
monitors, 2,048×2,560 matrix, 8-bit viewable gray, 500
cd/m2).
Two radiologists (specialzed in chest radiology) assessed the
CT scans retrospectively. Decisions on the CT findings were
reached by consensus. GGO is defined as hazy increased opac-
ity with preservation of bronchial and vascular margins. The
areas of GGOs were measured at five levels (at the levels of
the top of aortic arch, aortopulmonary (AP) window, left upper
lobe (LUL) bronchus, right inferior pulmonary vein, and the
top of left diaphragm ) using the area measurement tool of
the PACS. To calculate the extent of the lung injury, the sum
of the area of GGOs at the five levels were divided by the sum
1. Gastric lavage
2. Dithionite urine test 
3. Fuller’s earth, 100 g in 200 mL mannitol 
4.   A. Antioxidant (intravenous administration)
N-acetylcysteine          
L-glutathione   
Vitamin C 
Vitamine E 
Thioctic acid 
B. For renal preservation 
Furosemide
15% Mannitol 
C. Others 
Deferoxamine mesylate
Dexamethasone
5. Emergency hemoperfusion 
6. Key laboratory parameters
Blood chemistry: Blood urea nitrogen, Creatinine, Amylase, 
Lipase 
Electrolyte: Na, K, Cl
Artery blood gas analysis 
Total antioxidant status
Malondialdehyde
Table 1. Summary of treatment guidelines for acute paraquat
(PQ) intoxication
Fig. 1. The areas of GGO were  measured at  five locations (the top of aortic arch, AP window, LUL bronchus, right inferior pulmonary vein
and the top of left diaphragm respectively) using the measurements of the  free-pen tool of PACS. To calculate the percents of lung injury,
the sum of the areas of GGO (A) at the five levels were divided by the sum of the area of the total lungs (B) at the respective levels.  
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of the areas of the total lung at the respective levels. Some-
times, it is difficult to differentiate GGOs from consolida-
tion. In this study, if the area of focal consolidation is located
within the boundary of GGO, it was regarded as area of GGOs.
If the area of consolidation was located outside the area of
GGO, this area was not included in the area of GGO.
Statistics 
Data are presented as mean±SD and range of distribution
when the distribution of data was unusually wide. Compar-
ison of the parameters was performed with the t-test; but
the Mann-Whitney test was applied for the time lag after
PQ ingestion, estimated ingestion amount (mL), area with
GGOs on HRCT (%), aspartate minotransferase (AST), ala-
nine aminotransferase (ALT), amylase, and lipase because of
the unusually wide distribution of the raw data.
RESULTS
Of 119 subjects, 102 survived and 17 died of acute PQ in-
toxication. There was no difference between the survivors and
those who did not survive by age (42.4±12.3 yr vs. 44.6±
11.0 yr, P=0.488) or gender (male/female: 58/44 vs. 10/7, P=
0.880). The WBC count was higher in those that did not sur-
vive than those survived (17,336.5±5,283.6 μ L vs. 10,942.6
±4,452.2 μ L, P<0.001, Table 2). The estimated ingestion
amount of PQ was lower in the survivors than in the dead
(19.4±11.3 mL vs. 59.2±44.7 mL, P<0.001). Between
the survivors and those that did not survive there was no sig-
nificant difference in the interval between PQ ingestion and
arrival to the emergency room, (22.1±31.9 hr vs. 16.2±
18.2 hr, P=0.45). However, the plasma PQ levels were sig-
nificantly higher in those that did not survive than the sur-
vivors (2.6±4.0 μ g/mL vs. 0.2±0.4 μ g/mL, P=0.02).
The area of the lung with GGOs was 2.03±6.44% in the
survivors and 73.0±29.93 in those that did not survive (P<
0.001). The area of GGOs was zero in 40 out of 102 survivors
and it was larger than 80% in 9 out of 17 patients that did
not survive. Eight subjects (3 survivors and 5 non-survivors)
had between 20-40% GGOs. No patients survived when the
amount of GGOs was larger than 40%. In contrast, all patients
with GGOs smaller than 20% survived (Fig. 2).
DISCUSSION 
Plasma PQ levels are known to be an excellent prognostic
indicator for patient outcome (17-19). However, at the bed-
All parameters are measured at emergency room at first hospital day except ‘‘area of GGO’’. Time lag after PQ ingestion, ingestion amount (mL), area
of GGO, AST, ALT, amylase and lipase were compared with the Mann-Whitney Test (Range of data).
PQ, paraquat; HRCT, high resolution computerized tomography; AST, aspartate minotransferase; ALT, alanine aminotransferase.
Survivor (n=102) Non-survivor (n=17) P value
Sex (male:female)  58:44 10:7 0.880 
Age (yr) 42.4±12.3 44.6±11.0 0.488
Time lag after PQ ingestion (hr) 15.3±18.3 (1-70) 12.5±9.0 (3-33) 0.368 
Plasma PQ level (μ g/mL) 0.25±0.37 (0.001-2.00) 2.78±4.09 (0.07-13.69) 0.021
Estimated ingestion amount (mL) 19.1±10.7 (1-50) 60.3±45.8 (5-200) <0.001 
Area of consolidation on HRCT (%) 2.1±6.7 (0-39.4) 74.4±30.2 (24.3-100) <0.001
WBC (μ L) 10,942.6±4452.2 (3,460-22,010) 17,336.5±5283.6 (9,960-28,760) <0.001 
Hemoglobin (g/dL) 14.37±2 15.25±2.7 0.113 
Hematocrit (%) 41.7±5.2 42.3±5.3 0.647 
Platelet (10
3) 232.4±72.3 235.5±58.4 0.888 
Albumin (g/dL) 4.4±0.5 4.5±0.7 0.372 
AST (U/L) 32.8±26.6 (11-160) 37.8±31.5 (15-127) 0.331
ALT (U/L) 31.7±36.3 (6-277) 24.9±14.9 (8-57) 0.668 
Total bilirubin (mg/dL) 0.8±0.4 0.8±0.5 0.624 
Amylase (U/L) 174.5±192.1 (31-1,352) 224.1±190.9 (46-831) 0.041 
Lipase (U/L) 30.9±17.5 (4.1-133) 30.9±16.4 (3.6-59) 0.988 
BUN (mg/dL) 12.6±5.9 16.9±14.9 0.256 
Creatinine (mg/dL) 0.8±0.8 1.2±1.0 0.119 
Sodium (mEq/L) 141.7±4.9 140.9±8.0 0.610 
Potassium (mEq/L) 3.8±0.5 3.6±0.6 0.371 
Chloride (mEq/L) 104.4±4.8 103.5±5.6 0.478 
pH 7.4±0.1 7.4±0.1 0.968 
CO2 (mmHg) 34.4±4.8 31.4±6.8 0.100 
O2 (mmHg) 90.9±14.1 97.0±17.2 0.111 
HCO3 (mEq/L) 22.1±3.2 20.4±5.5 0.247 
Table 2. Comparison of parameters between survivors and non-survivors  HRCT in Paraquat Intoxication 639
side, it is difficult to predict survivors even when the PQ lev-
els are known. Recently, we published an analysis of our clini-
cal observations, which showed an association between plas-
ma PQ levels and clinical outcome in 375 patients with acute
PQ intoxication (20). Based on the information from the plas-
ma PQ levels it was hard to predict who would survive because
many patients died even at low PQ levels. Therefore, better
predictive measures are needed for patients presenting with
acute PQ intoxication. Because lung injury is the main cause
of death after acute PQ intoxication, the lung abnormalities
would be a better predictive factor. 
The initial pathology of PQ intoxication is an alveolitis,
which is later shown as GGOs in HRCT. In diagnosing the
lung injury caused by PQ, HRCT is employed as a sensitive
and specific tool. We evaluated the severity of the lung injury
by measuring the extent of involved lung. The results of this
study showed that there were no deaths when the area of GGOs
was smaller than 20% of the total lung volume. In addition,
there were no survivors when the area of GGOs was larger
than 40% of the total lung volume. When 20% and 40%
of the total lung volume was affected, some patients died and
others survived. 
For those patients who died within 7 days before they took
the HRCT, we presume that GGO might have developed
across their entire lungs. The GGO-inflicted patches were
distributed unevenly across the area. There was no such GGO
area in the 40 cases out of 119 survivors, more than 80% of
such inflicted area in the 9 cases out of the 17 non-survivors.
Eight cases were transitional between 20-40% of GGO trace
in the lung. In these transitional cases, 3 cases survived and
5 did not. 
In conclusion, given the fact that the minimum fatal PQ
level can be very low in practice (Fig. 2), the area of GGO in
the lung is an additional useful predictor for the survival,
especially when the PQ level is low.  
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